SphereBio
XSpheres™ therapeutic nanovehicles engineered to precisely deliver complex biological payloads directly inside target cells.
health AI / medtech / biotech
StagePre-Seed
Raised$224K
Founded2022
Employees7
LocationAventura, FL
About
We develop biotech platforms that efficiently deliver molecules to cells, training them to generate specific responses to tackle challenging health issues. Currently, we are using our platforms to offer pharmaceutical companies a novel approach to potentiate vaccines and therapeutics tailored to specific diseases, such as cancer.
Product
- Value proposition
- Non-viral intracellular delivery platform that enables precise delivery of complex biological payloads inside cells, leveraging modular XSpheres technology, AI, and nanotechnology to overcome intracellular barriers and enable therapies previously untreatable.
Founders
- Julieta Luz Porta — Co-Founder, COO/CEO
- Martin Guerrero — Co-Founder, Chief Executive Officer
- Guido Nicolás Molina — Co-Founder, Chief Scientific Officer
Products
XSpheres™ non-viral intracellular delivery platformOncoSpheres™ personalized cancer vaccines
Key features
Non-viral intracellular deliveryModular cargo designImmune modulationHigh yields (100,000 particles per cell)Ability to deliver complex biological payloadsAI-enabled Sphere Engine for protein design
Technologies
XSpheres™ non-viral nanovehiclesSphere Engine™ AI designModular bioplatformAdvanced nanotechnologySynthetic biology
Target conditions
cancer
Care settings
hospitalclinicin vitro / laboratory
Partnerships
Brigham and Women’s HospitalDana-Farber Cancer InstituteNYU Langone (collaborations)
Traction metrics
Lead product OncoSpheres™ personalized cancer vaccineIndustry recognition by biotech investors
News
- How SphereBio is Developing Scalable Solutions to Complex Health Issues - Meaningful Business · 2025-11-21T13:22:38.000Z
- SphereBio: Revolutionizing vaccines and cancer treatment - LatamList · 2025-02-25T14:00:00.000Z
- Julieta Porta - Meaningful Business · 2025-02-04T22:51:44.000Z
- 🚀 🧬 Julieta Porta lidera SphereBio en vacuna personalizada contra el cáncer | Descubre.vc · 2026-02-04T00:00:00.000Z
- SphereBio y su nanotecnología avanzada para combatir el cáncer · 2024-11-14T15:05:16.000Z
- Julieta Porta, la ingeniera mendocina que impulsa una nueva vacuna para combatir el cáncer - Ecocuyo · 2026-06-21T10:08:25.000Z
Browse similar startups
Related startups
- St Luke Heart Institute — Brooksville, FL
- Stackyon | Agentic AI for Healthcare Operations — Tampa, FL
- SWICFT Cardiology — Naples, FL
- Syntry Health — Lutz, FL
- Triangulate Labs — Boca Raton, FL
- Trinity OB Homecare Solutions — Miami, FL
- Spire Group, Inc — Las Vegas, NV
- Spirited Food — Hillsborough, NC
- Stanford Medical Billing Inc. — Fresno, CA
- Stipple Bio — Cambridge, MA
- STORC™ — Washington, DC
- Stresscare Behavioral Health — Toledo, OH
Profile updated Jul 29, 2026. Sources: xspheres.com, linkedin.com, forbesargentina.com, endeavor.org.ar
